lilly glp-1 injection Novo, buoyed by fast-growing drug sales Lilly's KwikPen Delivers Month of

Although the FDA has not approved it specifically for weight loss, research indicates that it may support weight reduction

Citation: Tveit MC, Gelfand ST, ** Simon JA

GLP-1 receptor activation slows gastric emptying, reduces appetite, and improves insulin sensitivity

Glucagon receptor activation increases your body's resting metabolic rate (you burn more calories at rest) and promotes lipolysis (the breakdown of stored fat into energy)

and negotiated prices paid by plans

Although lifestyle intervention that includes proper diet and exercise remains the cornerstone of managing obesity, achieving long-term weight loss poses a significant challenge